October 14-15, 2014
San Mateo County Event Center

Panel 1

How to integrate and implement new HealthTech tools in the ACO world.

John E. Mattison, MD

Chief Medical Information Officer, Assistant Medical Director, Kaiser-Permanente, Southern California

Directed the largest and first deployment of KP HealthConnect, Kaiser-Permanente’s revolutionary program to improve the quality and safety of healthcare through the use of information technology. This program supports the largest region of Kaiser Permanente with over 3 million lives and has been used by over 7,000 physicians in 13 hospitals and 140 clinics. His team of world class project managers completed the project more than a year ahead of schedule and nearly $260 million under budget. Kaiser Permanente has been recognized as the national leader for both outpatient and inpatient systems, leading the country for hospitals awarded with the top HIMSS level 7 designation, and receiving the prestigious Davies Award in 2012. His team has hosted dozens of international delegations who have studied this program, and John has consulted internationally on numerous Health IT issues.

Founding member of the KP Innovation Fund and Board of Directors, and reviews every innovation proposal for the national program.

Sponsored numerous innovation projects including direct text messaging to patients, Smartphone applications for healthcare consumers, Natural Language Processing for data mining, medication management tools using smartphones, and advanced decision support, behavioral economics for motivating healthy behaviors, among others.

Serves on the Innovation Challenge Board sponsored by Health 2.0 and the Office of the National Coordinator for Health IT.

Recently accepted an invitation to join a Washington DC-based 501c3 think tank, HealthTech www.HealthTechCouncil.org.

Read full bio →

David Sayen

Regional administrator, Centers for Medicare & Medicaid Services

David Sayen assumed the position of Regional Administrator of the Centers for Medicare & Medicaid Services, Region IX in February 2008. David is based in San Francisco, and his jurisdiction includes California, Arizona, Nevada, Hawaii, and the Pacific Territories. He replaces Acting Regional Administrator Charlotte Yeh, who is returning to her regular duties as Regional Administrator of the New England region of CMS.

David brings more than 29 years of Federal service and experience in health and human services programs to the position of Regional Administrator. Since 2002, he has served as Associate Regional Administrator for the Division of Medicare Health Plans Operations, leading all private health plan contract operations for Medicare Advantage and the Medicare Prescription Drug benefit in Region IX. From 1999 to 2002, he was the Associate Regional Administrator for the Division of Medicare Financial Management, where he ran the Medicare Contractor Financial Management and Program Integrity functions.

From 1998 to 1999, David led a team charged with ensuring that 11 Medicare claims processors successfully prepared for Y2K. From 1994 to 1998, he directed all Medicare managed care and fee-for-service customer service operations as Branch Chief, Medicare Managed Care Branch, in the Philadelphia Regional Office of CMS.

In 2003 David was named a Senior Fellow of the Council on Excellence in Government Fellowship, and he is also a member of the Adaptive Business Leaders Healthcare Roundtable of Northern California. He earned a bachelor’s degree in philosophy from Temple University, Philadelphia, PA in 1977 and an MBA with an emphasis on health administration from Temple University in 1991.

David lives with his family in Alameda, CA.

Read full bio →

Steve Myers

Chief Technology Officer, Optum Health Behavioral Solutions

Steve Myers has 17 years of experience providing direct information technology (IT) solutions to public sector behavioral health and medical programs in multiple states, including the country's largest public behavioral health contract in Maricopa County, Arizona. His primary focus is on behavioral health IT, business operations and implementations. His prior experience includes additional consulting work in the design of IT and business systems in the public sector environment and the US government.

Overall, Steve brings 27 years in system design and operations to Optum. His knowledge and solution design skills has been key to Optum winning key contracts and operationalizing them. He is a recognized and awarded innovation champion and leader who works incubating innovation, both inside and outside UnitedHealth Group. His years of experience leading have allowed him to effectively guide and direct Optum's Specialty Network development so that it meets the needs of the consumers, providers and stakeholders.

Myers has degrees in business administration and management, IT, and criminal justice. Regional administrator, Centers for Medicare & Medicaid Services.

Read full bio →

Paul Markovich

President and CEO, Blue Shield California

Paul Markovich is President and CEO of Blue Shield of California, a three million member not-for-profit health plan serving the state's commercial, individual and government markets. Markovich assumed the position on January 1, 2013.

As President and CEO, Markovich drives Blue Shield's mission to ensure Californians' access to high-quality health care at an affordable price. A 16-year Blue Shield veteran, Markovich previously served as COO, in which capacity he oversaw health care services, network management, e-business, marketing, product development, customer operations and Blue Shield's three business units offering medical and specialty benefits coverage.

Prior to his position as COO, Markovich served as senior vice president of Blue Shield's large group business unit and oversaw the CalPERS business unit, significantly boosting membership and revenues in both roles.

This is Markovich's second stint with Blue Shield. Leading the company's product development unit in the late 1990s, Markovich introduced numerous products and services, including the first California HMO to allow self-referrals to specialists, and the Blue Shield website.

While away from Blue Shield, Markovich spent two-and-a-half years as an entrepreneur, co-founding a consumer-driven health plan. He then joined Definity Health, another consumer-driven plan based in Minneapolis, before returning to Blue Shield.

Markovich started his professional career as a management consultant with Booz Allen Hamilton in New York. He is a North Dakota native, a graduate of Colorado College (where he played Division I hockey), a Rhodes Scholar, husband and father. He is the Chair of the California Association of Health Plans and serves on the board of directors of the Bay Area Council.

Read full bio →

Michael Blum, MD

Chief Medical Information Officer, UCSF

Dr. Michael Blum is the Associate Vice Chancellor for Informatics and a Professor of Medicine in Cardiology at UCSF. As an active clinician, Dr. Blum is passionate about wellness and prevention of heart disease through lifestyle.

Prior to his medical career, Dr. Blum was trained as an engineer, and he applies his expertise in technology to health care as UCSF’s Chief Medical Information Officer and Director of the Center for Digital Health Innovation at UCSF which develops and evaluates novel applications, devices, and platforms in pursuit of Precision Medicine. He led the successful $165M enterprise deployment of Epic’s electronic health record at UCSF and the development of a large scale research data repository.

Dr. Blum has been involved with numerous start-ups and early stage companies. He was the clinical lead on the joint Motion Computing - Intel development and launch of the first successful healthcare-specific tablet computer, the Motion C5.

Read full bio →


Keynote: Anne DeGheest, Review of HealthTech Opportunities

Anne DeGheest

Founder, Managing Director HealthTech Capital

Anne has 25 years investing and mentoring experience with MedStars, and has been a pioneer entrepreneur and investor in the emerging HealthTech sector. Companies in which Anne has been involved have been market changers and have grown to $6 billion market cap. She has startup operating experience as CEO and VP as well as public and private board positions. Anne earned a Master in Business Engineering, Brussels and an MBA, Harvard.

Panel 2

What are the Unmet Needs of the Providers? New care delivery models.

Amir Dan Rubin

President & CEO, Stanford Health Care

Amir Dan Rubin serves as President and CEO of Stanford Health Care in Palo Alto, California. Stanford Health Care seeks to serve humanity through science and compassion, one patient at a time, through its commitment to care, educate, and discover. As a part of Stanford University, the medical center has made groundbreaking impacts in medical innovation, garnering five Nobel prizes to date. Stanford seeks to deliver leading edge and highly coordinated care, and is recognized as a national leader in quality and safety. Stanford is also amongst the nation's most advanced adopters of information technology, and is currently undergoing a major modernization project to develop new state-of-the-art facilities.

Amir earned a Master's in Business Administration from the Ross School of Business at the University of Michigan in Ann Arbor, a Master's degree in Health Services Administration from the University of Michigan in Ann Arbor, and a Bachelor's degree in Economics with a minor in Business Administration from the University of California, Berkeley Amir Dan Rubin serves as president and CEO of Stanford Hospital & Clinics, which seeks to serve humanity through science and compassion, one patient at a time, through its commitment to care, educate, and discover. As an integral part of Stanford University, the medical center has made groundbreaking impacts through innovative treatments and cures, through advanced information technology, and soon, through its state‐of‐the art new hospital. Stanford is recognized amongst the very best in quality and outcomes, and is focused on delivering an outstanding patient experience through the combination of leading edge and coordinated care.

Prior to Stanford, Amir served as Chief Operating Officer for the UCLA Hospital System, responsible for the operations of the Ronald Reagan UCLA Medical Center, Mattel Children's Hospital at UCLA, the Resnick Neuropsychiatric Hospital at UCLA, Santa Monica‐UCLA Medical Center and Orthopedic Hospital, and an array of outpatient centers across the west side of Los Angeles. Prior to UCLA, Amir served as Chief Operating Officer for Stony Brook University Hospital, a comprehensive academic medical center on Long Island, New York. Prior to Stony Brook, Amir served as Assistant Vice President of Operations for Memorial Hermann Hospital in Houston, Texas, an 818‐bed, level‐1 trauma center which serves as the primary teaching hospital for University of Texas—Houston, Medical School. Prior to that role, Amir served as Director of Business Development for the corporate parent of the 12‐ hospital Memorial Hermann Healthcare System.

Amir earned a Master's degree in Business Administration and a Master's degree in Health Services Administration from the University of Michigan, and a Bachelor's degree in Economics with a minor in Business Administration from the University of California, Berkeley. Amir lives with his wife Nicole Rubin and his two children in Portola Valley, California.

Read full bio →

Chris Willrich

Regional Vice President Strategy & Business Development, Sutter Health

Chris Willrich is Regional Vice President Strategy & Business Development with Sutter Health. In this role he oversees physician, service line and capital planning, as well as directing in-region joint venture and merger and acquisition activity.

Prior to his eight years with Sutter, Chris spent four years as a Principal with MedBridge Development, which focuses on syndicating physician investment in surgery centers, medical office buildings and ancillary services. Chris began his career doing strategic planning and partnership development work in the high technology sector. He received his BA from Yale University and his MBA from the Kellogg Graduate School of Management at Northwestern University. He lives in the Oakland hills with his wife and two children.

Seth Frazier

Chief Transformation Officer, Evolent Health

Seth oversees Evolent Health’s client transformation practice. He most recently served as the Chief Transformation Officer for the Geisinger Health System prior to joining Evolent. His responsibilities included providing business leadership to large-scale innovation projects within the health system (e.g., Geisinger Accelerated Performance Program) and external consulting for Geisinger Ventures. Prior to Geisinger, Seth was Senior Vice President, Strategic Services for The Children’s Hospital of Philadelphia (CHOP). Seth led CHOP’s proton therapy development initiative, national contracting for tertiary services and strategic plan development and management. Before assuming the strategic services role, Seth had executive responsibilities for CHOP-affiliated Children’s Health Net, a pediatric managed care organization that developed and managed a globally capitated 100+ PCP network under contract with the dominant regional HMO. Seth came to CHOP after a 9-year consulting career with a large national health care firm. His practice areas included clinical resource management, managed care, service line strategy, hospital redesign and strategy.

Wen Dombrowski, MD

Aging, Healthcare, & Technology Advisor

Wen Dombrowski, MD, MBA is a geriatrics physician executive that brings a unique perspective to healthcare with her clinical, policy, business, social media, and technical expertise. She develops technology and business solutions to help vulnerable populations with complex medical and social needs -- including older adults, people with disabilities, patients with life-limiting illnesses, and the urban poor. Dr. Dombrowski also advises health tech startups, aging and technology industry organizations, and other healthcare stakeholders. She enjoys connecting people, ideas, and resources to get things done.

Dr. Dombrowski was previously Chief Medical Information Officer for a homecare provider, Clinical Informatics Director at a multi-specialty network of outpatient practices, and Medical Director at a special needs managed care plan for Medicaid-Medicare dual-eligible seniors. She is regularly invited to speak at conferences about health information technology, social media, aging and workforce development.

Read full bio →

Panel 3

Creating Winners: Lessons learned from stars.

Owen Tripp

Co-Founder and CEO, GrandRounds Health

As co-founder and CEO of Grand Rounds, Owen believes that patients will achieve better healthcare outcomes through the intersection of technology, medical expertise, and extraordinary patient care. Prior to Grand Rounds, Owen co-founded Reputation.com and grew the company into the worldwide leader in online reputation and privacy management; he also held executive positions at eBay and Accenture (Health and Life Sciences Practice). Owen received a BA with honors from Trinity College and received an MBA from Stanford Graduate School of Business. He was recently named an “Innovator” in the Institute for Healthcare Consumerism’s 2013 Superstar Awards

Bryan Roberts

Partner, Venrock

Bryan Roberts, Ph.D. joined Venrock as a Kauffman Fellow in 1997. He is based in Venrock's Palo Alto office and focuses on a broad range of healthcare investments. Bryan is currently Chairman of the Board of Directors of Achaogen, Castlight Health, and Ironwood Pharmaceuticals (NASDAQ: IRWD) and also serves on the Board of several other companies, including Ariosa Diagnostics, Doctor on Demand, Grand Rounds, Intarcia, Kyruus, and Zeltiq (NASDAQ: ZLTQ). Past investments include athenahealth (NASDAQ: ATHN), CodeRyte (acquired by 3M), Ikaria (acquired by Madison Dearborn) Illumina (NASDAQ: ILMN), Sirna Therapeutics (acquired by Merck) and Xenoport (NASDAQ: XNPT). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has been the highest-ranking healthcare investor on Forbes’ Midas List since 2008.

Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University. He previously held positions in corporate finance at Kidder, Peabody & Co and received his B.A. from Dartmouth College.

Read full bio →

Jeff Tangney

CEO, Doximity

Jeff Tangney started Epocrates from his Stanford dorm room in 1999 and led its growth over a decade to IPO. In 2010, he started Doximity with the goal of building a free, secure medical network. It has since grown to over 40% of US physicians as active, verified members. Previously, Jeff worked at Goldman Sachs and ZS Associates. He was named E&Y Entrepreneur of the Year Northern California in 2005 and PharmaVoice Top 100 Most Inspiring in 2006.

Peter Hudson, MD

Co-founder, iTriage

Dr. Peter Hudson is a physician and entrepreneur with more than 20 years of experience founding and growing healthcare-related businesses.

In 2008, Hudson co-founded iTriage, now a subsidiary of Aetna, along with Dr. Wayne Guerra. Dr. Hudson continues to advise on the strategic vision for the consumer healthcare technology that empowers individuals to make better healthcare decisions. The iTriage exit was considered the first significant exit in the mobile health space and has fast become the leading personal healthcare technology with more than 11 million downloads.

Dr. Hudson was a CNN Healthcare Entrepreneur of the Year in 2012 and the Colorado Technology Association's 2013 Entrepreneur of the Year. He was a guest of the First Lady at the 2013 State of the Union Address. He has practiced emergency medicine in a wide range of environments, from country trauma centers to nonprofit community hospitals from Nepal to Guatemala to Kenya and the U.S. Based in Denver, Colo., Hudson is an adventure enthusiast and lives with his family near the Rocky Mountain continental divide. He is a frequent speaker on healthcare and technology.

Read full bio →

Jeff Arnold

Chairman & CEO, Sharecare

Jeff Arnold is Chairman and CEO of Sharecare, a health and wellness engagement platform he founded with Dr. Oz, in partnership with Harpo Productions, Sony Pictures Television and Discovery Communications. Sharecare helps people maximize their human potential by connecting them to personalized health resources including high-quality information from experts, clinical decision support tools, interactive programs and local healthcare providers.

Previously, Arnold was Chairman and CEO of HowStuffWorks.com, an award-winning online resource which he sold to Discovery Communications, where he served as Chief Digital Strategy Officer, and Chief Architect of The Curiosity Project until December 2011.

At the age of 28, he founded and served as CEO of WebMD Corporation, the first healthcare company to harness the power of the Internet to create a destination for consumers, healthcare institutions and physicians to find trustworthy medical information.

He was inducted into the Honor Society of Nursing, Sigma Theta Tau International, as an Honorary Member in recognition of his superior achievements and contributions to the advancement of nursing and health care at national and global levels. Arnold also has been honored by the World Economic Forum; inducted into the Technology Hall of Fame of Georgia; named Entrepreneur of the Year, Southeast Region by Ernst & Young; and received the prestigious Phoenix Award, which recognizes companies and individuals who embody strength, tenacity and leadership in Georgia’s healthcare information technology industry.

Currently chairman of Forbes Travel Guide, Arnold also has served on numerous boards for public, private and charitable organizations over the years.

Read full bio →

Panel 4

Retail medicine? Changing Aging at Home? Health vs. Care Anywhere?

Pat Basu, MD

MD MBA, Chief Medical Officer, Doctor on Demand

Board Certified Physician, Dr. Pat Basu, is the Chief Medical Officer of Doctor on Demand. He was previously the Chief Operating Officer, Chief Medical Officer, and Director on the Board at vRad – the largest technology enabled national radiology practice. Dr. Basu also served on the State Board of Health in Illinois.

Dr. Basu helped shape economic and health care agendas during his time as a White House Fellow, and has also held faculty and research appointments at Stanford University that centered on health care cost, access and quality. Throughout his career he has consulted for Fortune 500 companies, venture capital firms, and major medical centers on growth strategy, cost containment, revenue enhancement, and operational optimization. Dr. Basu holds a Medical Doctorate and Masters in Business Administration from University of Chicago. He holds a degree in Mechanical Engineering from University of Illinois.

Jody Holtzman

Senior Vice President, Thought Leadership, AARP

Jody Holtzman has more than two decades of experience helping companies develop and implement competitive strategies and achieve their strategic market goals. At AARP, he leads the Thought Leadership group, where his focus is to stimulate innovation and entrepreneurship in the market that benefits people over 50. This involves areas such as health innovation, the future of technology and the 50+, technology design for all, and 50+ entrepreneurship. It also involves developing partnerships with non-traditional players for AARP, such as the venture capital community, and the consumer electronics and technology industries. Previously, Jody led AARP’s Research and Strategic Analysis group.

Before joining AARP, Jody was in senior leadership roles in several strategy consulting firms. He was a Director of Global Strategy and Planning, and led the Market Intelligence Network of PricewaterhouseCoopers. Before that, he was Vice President of Consulting for FutureBrand, where he helped clients develop and implement competitive brand strategies.

Jody is a frequent speaker on the opportunities and challenges presented by the demographic wave. He has led numerous workshops on competitive strategy and organizational performance, and his work has been published in the Journal of Business Strategy, Competitive Intelligence Magazine, The Competitive Intelligence Anthology, and Making Cents Out of Knowledge Management. He has a graduate degree in international political economy from the University of Chicago.

Read full bio →

Barb Johnston

CEO and Co-Founder of HealthLinkNow, Inc

Barb Johnston, CEO and Co-Founder of HealthLinkNow, Inc. has extensive expertise as an executive in the business, legal and policy aspects of the Telemedicine industry. Ms. Johnston is the Project Director of the Patient-Centered Medical Home/Mental Health program funded with $7.7 million from the CMS Innovation Initiative 2012-2015.

Ms. Johnston previously raised $23 million to enable the development of the 10 rural telemedicine networks targeting underserved communities in California when she was the Executive Director of the California Telemedicine and eHealth Center from 2003 to 2007. Ms. Johnston authored a well-accepted review of telemedicine activities and business models for the California Healthcare Foundation. (www.chcf.org) in 2007. She serves on a number of Health Information Technology and Telemedicine Boards, is a past Board Member of the American Telemedicine Association (ATA), and authored the premier research study on the delivery of homecare by telemedicine. She is widely respected and networked nationally in the telemedicine community and is an expert on telemedicine business models, policy and reimbursement, having been involved on a number of occasions in successfully developing telemedicine reimbursement legislation. She has extensive high level executive management experience in both public and private sectors, including having been the Executive Director of the Medical Board of California where she was responsible for a budget over $53 million and 278 staff. She was also the Chief Operating Officer of a private telemedicine company in Australia. Ms. Johnston is a founding and current director of the California Emerging Technology Fund.

Read full bio →

Rick Altinger

CEO, Glooko

Mr. Altinger has spent 20 years in the technology industry, concentrating on healthcare information technologies for the last 15 years. Prior to his role as CEO at Glooko, Mr. Altinger was at Intuit, where he launched the healthcare division’s provider services and drove the effort that resulted in Intuit acquiring Medfusion in May 2010. Medfusion, now the core of Intuit Health, is the leading supplier of patient-provider communication and patient portal services that improve healthcare by delivering groundbreaking clinical, administrative and financial services.

Prior to joining Intuit, Mr. Altinger was an Executive Vice President at AdvancedMD, a Practice Mgt/Electronic Health Record company that he helped through a turnaround. Mr. Altinger was also an early employee at Healtheon/WebMD where he served as Vice President of Business Development setting product strategy and driving major acquisitions including WebMD, Envoy, Medical Manger, Kinetra and MedE America. Prior to his business development role at Healtheon, Mr. Altinger played numerous roles including leading product management, account management and systems integration.

Mr. Altinger received a B.S. in mechanical engineering and an M.S. in engineering management from Stanford University.

Read full bio →

Mike Payne

Chief Commercial Officer and Head, Medical Affairs, Omada Health

Mike is a commercial leader who has worked with companies in almost every sector of health care. He believes that small companies with new ideas can change healthcare, but only if they work hand-in-hand with current leaders in the healthcare world. He is committed to making Omada into the leader of a new generation of health providers focused on evidence-based digital health programs for specific, complex diseases. Mike joined Omada from biotechnology leader Gilead Sciences, where he spent 6 years as Senior Director of Commercial Strategy, with experience in new product development, M&A, and marketing. Mike was previously with the healthcare practice at McKinsey & Company where he worked with healthcare clients in biotechnology/pharma, medical devices, health systems, and global health. Mike has an MBA from Stanford Business School as well as an MSc in Health Services Research from Stanford Medical School.

Panel 5

Venture Pitches and Audience Votes

Joel Krikston

Managing Director, Merck Global Health Innovation Fund

Joel Krikston is a Managing Director with Merck’s Global Health Innovation Fund, LLC (“GHI”). Joel is focused on identifying new investment opportunities in Health Information Technology and Technology Enabled Solutions with an emphasis on Decision Support, Accountable Care and Population Health. Joel is currently on the Board of MedCPU, Inc., is a Board Observer at Electrocore, LLC and is GHI’s representative to the New York Digital Health Accelerator.

Mr. Krikston has over 20 years of experience in healthcare innovation. Prior to joining Merck GHI in 2013, he was an Investment Principal at Johnson & Johnson Development Corporation, leading the group’s efforts in healthcare technology and diagnostics while also supporting medical devices and pharmaceuticals. He has previously served on the Boards of GetWellNetwork (acquired by Welsh Carson in 2012) and Imacor. During Mr. Krikston’s seven years with J&J, he served in a range of business development roles at both the corporate and operating company level focused on the identification, formation, development and launch of new businesses in emergent healthcare segments.

Prior to joining Johnson & Johnson, Joel spent over eight years as an investment banker, covering an array of healthcare clients and included experience at BNP Paribas, JPMorgan and ABN Amro. Joel has an MBA with honors from the Stern School of Business at NYU and completed his Bachelor’s degree in Finance and International Business at Fairfield University.

Read full bio →

Wende Hutton

Managing Director, Canaan Partners

Healthcare investor Wende Hutton brings 20 years of experience to identifying, investing in and building companies that are changing the practice of medicine. She has facilitated bringing over a dozen medical devices and drugs to market, and currently sits on the boards of Aldea Pharmaceuticals, Butterfly Health, Chimerix (CMRX), Dermira, Labrys Biologics, ReVision Optics, Theraclone Sciences and Transcend Medical.

Wende joined Canaan in 2004, and her life sciences track record includes 6 IPOs and 4 acquisitions. She began her venture career at Mayfield Fund in 1993, where she worked closely with the founding teams of Heartstream (HPQ) and Northstar Neuroscience (NSTR). Earlier in her career, Wende held senior operational management positions at GenPharm International and Nellcor. Wende holds an AB in human biology from Stanford University and an MBA from Harvard Business School, where she was a Baker Scholar.

Read full bio →

Casper de Clercq

Partner, Norwest Venture Partners

With over 30 years of experience, Casper is a veteran of the medical device and life sciences industry. He brings extensive operating knowledge to Norwest Venture Partners having led marketing and commercialization efforts for cardiovascular device, specialty pharmaceutical, and diagnostic companies. Casper focuses on mid-to-late-stage investments in medical devices, specialty pharmaceuticals, healthcare services, and healthcare IT. Along with his current board seats at Intersect ENT, iRhythm Technologies, and Simpirica Spine, Casper has invested in Misfit Wearables. He was previously on the board of Basis (acquired by Intel).

Jonathan Root, MD

General Partner, USVP

As a physician, Jon Root evaluates investments in the medical field with a practitioner's eye. A common investment criteria when evaluating business opportunities in the biotechnology or medical devices fields is: does this solution meet, or begin to address, an unmet clinical need? Jon goes beyond that: is the innovation easily usable?

"The greatest idea in the world will not be successful if it's not practical to use," says Jon. Jon spent nine years in clinical practice before joining USVP in 1995 as a Ewing Marion Kauffman Fellow in venture capital. He became a general partner in 1997. Before USVP, Jon was on the faculty and clinical staff at The New York Hospital-Cornell Medical Center in New York City. There he was an Assistant Professor of Neurology and Director of the Neurology-Neurosurgery Intensive Care Unit. He is board certified in neurology.

"Efficacy always dictates the doctor's choice of procedure or method," Jon notes. "It's critical to gain feedback from the people who will actually use your product," he says. Whether it's less invasive biopsy procedures or simple changes that make a tissue closing easier, considering the doctor as well as the patient helps optimize product design, Jon adds. "If an easier way is just as effective, there is opportunity for companies to make a difference. If a drug is as effective taken orally versus intravenously, the doctor will probably choose a pill -- if it's available."

Jon is currently on the boards of USVP portfolio companies Articulinx, Cleave Biosciences,eFFECTOR Therapeutics, Inari Medical, Omada Health, OncoMed (Nasdaq: OMED), and Sequent Medical; he is active with USVP's investment in Ascenta and Castlight Health (Nasdaq: CSLT). Jon is a former board member for the National Venture Capital Association (NVCA).

Jon maintains relationships with leading medical schools on both coasts and enjoys helping entrepreneurs make meaningful connections. He helps entrepreneurs connect with leading specialists to gain input on product design issues.

Jon holds an A.B. in Economics from Dartmouth College, an M.D. from the University of Florida College of Medicine, and an M.B.A. from Columbia University.

Jon enjoys golf, plus he likes to swim and ride bicycles with his wife and two sons.

Read full bio →

Session 1: Employers: new role at the forefront of healthcare innovation?

Kent L. Bradley, MD

MD, MPH, MBA, Senior Vice President, Chief Medical Officer, Safeway, Inc., President, Safeway Health

Kent is the Chief Medical Officer for Safeway, Inc., a fortune 100 company with over 150,000 employees and is responsible for supporting the company's portfolio of health care programs including its employee and consumer wellness and prevention activities. He is the President of Safeway Health, a subsidiary of Safeway Inc. that provides solutions that engage employees to become active health consumers that results in improved health and reduced cost.

Kent is a graduate of the United States Military Academy and has a Master in Public Health from the University of Minnesota, a MBA from the University of Denver, and his Medical Degree from the Uniformed Services University of Health Sciences, Bethesda, MD. He is Board Certified in Preventive Medicine. He is an adjunct professor at the University of Denver, Daniels College of Business Executive Education program.

Read full bio →

Lauren Vela

Executive Director, Silicon Valley Employers Forum

Lauren Vela has served as the Executive Director of the Silicon Valley Employers Forum since 2008. SVEF is a coalition of over 35 large high tech companies focusing on both US and global employee benefits issues. Lauren interfaces directly with member companies, advising on company-specific issues, offering strategic direction for collective projects, facilitating the sharing of best practices and systemizing the companies’ data benchmarking.

Previously, Lauren was Senior Manager, Value Based Purchasing at the Pacific Business Group on Health where she managed a range of purchaser initiatives and the annual eValue8 Health Plan assessment. During Lauren’s tenure with PBGH, she has directed and worked on various projects including CALINX (Health Information Improvement) and P-GO (Provider Group Oversight and Improvement).

Prior to joining to PBGH, Lauren was employed by the Memorial Health Care System in Houston where she developed and directed a worker's compensation managed care program that administered integrated benefit plans and was the Manager of Product Development and Market Research for Memorial/Sisters of Charity HMO.

Lauren holds a master's degree in business administration from the University of Houston, and has completed all required course work towards a doctorate in public health at the University of Texas, Health Science Center in Houston.

Certifications: Certificate in Global Benefit Management by IFEBP

Read full bio →

Ali Diab

Co-Founder and CEO, Collective Health

Ali Diab is a Co-founder and the CEO of Collective Health, a cloud-based self-insurance platform that enables employers to achieve health insurance independence. Ali has more than 15 years of technology startup and executive management experience, and a strong personal motivation to improve the quality and cost of company-sponsored healthcare after experiencing a major health problem while employed at a growing technology company.

Prior to co-founding Collective Health, Ali was VP of Product Management and Business Operations at AdMob, a leading mobile advertising company, acquired by Google in 2010. Previously, Ali held executive and management positions at Goldman Sachs, Microsoft and Yahoo!. Ali is a graduate of Stanford and Oxford universities.

Session 2: Big Data Analytics: New data display? Making data actionable?

Dr. Nathan Gunn

President of Population Health and Analytics business, Valence Health

Dr. Gunn oversees a software and services business unit with more than 100 employees who are dedicated to aggregating, standardizing and analyzing more than 100 million patient encounters a year. Valence’s Population Health solutions help clients better manage clinical risk and improve quality across the care continuum by using real-time, clinical data to drive relevant and credible provider-oriented analytics. Prior to joining Valence, Dr. Gunn served as Chief Operating Officer of Verisk Health, where he was responsible for Verisk Health's unified business operations. Prior to that, Dr. Gunn served as Senior Vice President of Clinical Solutions at D2Hawkeye until its acquisition by Verisk. Dr. Gunn joined D2Hawkeye from McKinsey Company’s healthcare practice, where he served as a management consultant. Dr. Gunn completed his residency in Internal Medicine at the University of California in San Francisco and received his BA in Molecular Biology from UC Berkeley.

John de Souza

President, Consumer Health Division at Physicians Interactive

A serial entrepreneur, John has founded and held senior management positions in several startup companies. For eight years, John was the president and CEO of MedHelp, the world's largest health community, which was recently acquired by Physicians Interactive. John co-founded Flash Communications, a startup company that developed real-time two-way messaging systems acquired by Microsoft.

John was Co-Founder and Director of Smartleaf, a financial software company that provided account management solutions, and later, Vice President of Business Development and Marketing at DESoFT, a startup company acquired by Merrill Lynch that developed online real-time brokerage systems for retail brokerage firms. John started his career in healthcare performing research on guidance systems for robotic surgery at IBM T. J. Watson Research Center. Additionally, he was the head of the Technology Practice in Goldman Sachs' Private Equity Group investing in healthcare and technology. John received a B.S. and M.S. in Computer Science and Electrical Engineering from the MIT and an MBA from College des Ingenieurs in France.

Alan Stein, MD

VP Healthcare Technology, Autonomy / HP Software

With twenty years of experience in medical technology, Dr Alan Stein brings both breadth and depth of knowledge, bridging the gap between medical, technical and business experience.

Dr Stein holds a Medical Doctorate and a Doctor of Philosophy in biophysics and molecular biology from the University of Pennsylvania. After training in internal medicine at the Hospital of the University of Pennsylvania, Dr Stein pursued his passion for advancing medical technologies, through innovation and commercialization.

Dr Stein is a published author in both academic and industry journals and has worked with for-profit and not-for-profit entities, as diverse as 3M and The Helmsley Charitable Trust, working to improve the state of healthcare through better technology. He has mentored entrepreneurs at the Wharton School of Business and retains ongoing ties to academia and research. He now serves as lead for Autonomy Healthcare, subject matter expert, and a liaison between medical, technical, and business communities.

Read full bio →

Murray Brozinsky

Chief Strategy Officer, Healthline

Murray Brozinsky has more than 20 years of experience founding, operating and advising high growth technology firms. In his current role as Chief Strategy Officer for Healthline, Murray drives the company’s strategic direction and oversees its major partnerships. He has spoken at numerous industry conferences on various health information technology topics and trends. He holds a B.S. in Finance and a B.A. in Philosophy from the University of Pennsylvania, an M.S. in Engineering from Northwestern University’s McCormick School of Engineering and Applied Science, as well as an M.B.A. from Northwestern University's Kellogg and McCormick schools. Murray also sits on the board and/or advisory board of numerous tech start-ups.

Session 3: Public and Private Insurance Exchange

Lisa Suennen

Managing Partner, Venture Valkyrie

Lisa Suennen is Managing Partner at Venture Valkyrie Consulting, LLC, a consulting firm providing advisory services to companies, organizations and private equity firms in the healthcare field. Additionally, Lisa is a Senior Advisor to Psilos Group, a healthcare-focused venture capital and growth equity firm that focuses on the healthcare information technology, healthcare services and medical device sectors. Lisa was a co-founder of Psilos Group and a Partner at the firm from 1998-2014.

Prior to Psilos, Lisa was at Merit Behavioral Care (formerly American Biodyne, Inc), an $800mm behavioral healthcare company where she held various senior executive roles from its early start-up days through exit. Previously, Lisa held various positions in marketing and product management in companies in the high technology field.

Lisa is currently a a Board Member of the Dignity Health Foundation, and Board Member of health IT company Beyond Lucid Technologies, a Board Member of medical device company AngioScore, a member of the Qualcomm Life Advisory Board, and an Advisor to the California Health Care Foundation Innovation Fund. Lisa also serves as an Advisor to innovation consulting firm Accelevate, Inc. She previously served as a member of the Advisory Board of the U.S. Health and Human Services Office of the National Coordinator Investing in Innovations program.

Lisa holds an M.A. in political science, a B.A. in political science and a B.A. in mass communications, all from the University of California, Berkeley, where she is now Vice Chair of the National Advisory Council of the Institute of Governmental Studies at the University. Lisa is also a visiting lecturer at the U.C. Berkeley Haas School of Business where she teaches the annual course on healthcare venture capital.

Lisa also writes a widely read blog on healthcare and healthcare investing at www.venturevalkyrie.com. She has recently published her first book, entitled: Tech Tonics, Can Passionate Entrepreneurs Heal Healthcare with Technology, coauthored with Dr. David Shaywitz.

Read full bio →

Bryce Williams

Managing Director / CEO Extend health, Exchange Solutions for Towers Watson

Bryce Williams is Managing Director of Towers Watson’s Exchange Solutions business segment. Towers Watson is a global leader in HR consulting services and operates the U.S.’s largest private Medicare exchange as well as exchanges for all workforce populations, including part-time and full-time employees. Mr. Williams was Ernst & Young’s Entrepreneur of The Year in Business Services for Northern California. He served as senior vice president of marketing and business development for eHealth, Inc. before founding Extend Health, which was ranked no. 94 on Inc. magazine’s 2010 Inc. 500 list of the fastest-growing companies. Towers Watson acquired Extend Health in 2012.

Jeff Rideout, MD

Senior Medical Advisor, Covered California

Dr. Rideout is currently Senior Medical Advisor for Covered California, the Health Insurance Exchange for the State of California. In this role Dr. Rideout oversees all clinical quality, network management and delivery system reform objectives for Covered California as outlined in its model contract with partner health plans and their physician and hospital partners.

Previously Dr. Rideout was SVP, Chief Medical Officer for The TriZetto Group and also served as the Chief Medical Officer and global leader of the healthcare division for Cisco Systems Internet Business Solutions Group. While at Cisco, Dr. Rideout also served as a member of the American Health Information Community (AHIC’s) Chronic Care Workgroup for the US Department of Health and Human Services. Prior to Cisco, Dr. Rideout was Chief Medical Officer and SVP for Blue Shield of California and head of Quality Management for Blue Cross of California/WellPoint.

Dr. Rideout is a volunteer physician and Board of Directors member for Medical Teams International, an international medical relief organization. He is also currently on the board of Contra Costa Interfaith Housing, which provides permanent housing to low income families in the Contra Costa County in California. He also serves on the board of the Pacific Business Group on Health and the Integrated Healthcare Association. Dr. Rideout is also a faculty member at the UC Berkeley Haas School of Business, teaching on topics related to healthcare technology, services and innovation.

Dr. Rideout completed his residency training in internal medicine at University of California, San Francisco. He received his medical degree from Harvard Medical School and his undergraduate degree from Stanford University. He also holds a master’s degree in Philosophy, Politics, and Economics from Oxford University where he studied as a Rhodes Scholar.

Read full bio →

October 14, 2014


Gale Richards

Partner, Bioquest

Gale Richards has built and developed senior leadership teams for fast-growing Healthcare Technology companies for over 25 years. As both a seasoned executive recruiter and a hands-on sales and marketing leader in the healthcare space, Gale knows what it takes to understand a company’s DNA and build the right teams to accomplish its mission.

As a partner at BioQuest since 2003, Gale has become an essential advisor to CEOs, board members and venture capitalists as they search for exactly the right talent for their senior leadership teams. Gale’s search experience is international and includes C-suite, board members and senior executives for every cross-functional role. Gale’s sectors of expertise include: Digital Health, Medical Devices and Diagnostics.

Prior to her career in Executive Search, Gale held executive level positions leading sales and marketing teams at Lumedx and Spacelabs Medical. During her 13-year tenure at Spacelabs, the company grew from a $25M private company to a $300M global leader in patient monitoring.

Gale is an active investor, as a member of Life Science Angels since 2008 and serves as a mentor for the Entrepreneurship Center at UCSF. Gale received her Bachelor of Science degree in Nursing from Texas Woman’s University and practiced as a registered nurse in emergency medicine.

Read full bio →

James M. Sweeney

Chairman, Tangramcare

James M. Sweeney has founded ten health care product and service companies including Caremark, Coram, Bridge Medical and CardioNet. None of the ten have failed. Caremark was sold to CVS in 2007 for $24 billion and they recently announced the purchase of Coram for $2.1 billion. CardioNet reached nearly $1 billion value shortly after their IPO in 2008.

Jim has successfully taken four companies public, led an LBO resulting in a 650% return to investors in less than four years, raised over $2 billion in financing for his various companies including $500 million in venture capital, $700 million in debt financing, $400 million in four IPO’s – and sold two companies for over $1 billion.

He has been involved in buying, selling or taking public over 20 healthcare product and service companies. Acknowledged as the founder of the multi-billion dollar home infusion therapy industry, Jim founded Caremark, the industry pioneer and leader.

His recognition and acknowledgments includes two Ernst & Young Entrepreneur of the Year awards as well as being inducted into the World Hall of Fame. Alumnus of the year recognition from his alma mater San Diego State University, Corporate Directors Forum, lifetime achievement award, and recipient Triple Tree iAwards for Connected Health.
Jim’s serial entrepreneurship, was also the subject of a laudatory Page One Wall Street Journal article.

Read full bio →

Dave Thornton

Chief Talent Officer, Evolent Health

Dave Thornton oversees the recruitment, development and engagement of all Evolent Health employees. Dave is responsible for establishing the company's talent foundation and building programs that foster and grow the Evolent culture. Prior to joining Evolent, Dave held a variety of HR executive positions at AOL, Inc. including both line HR and Center of Excellence roles, most recently as the company's VP of Talent Management. Dave began his career working with Fortune 500 clients as an organizational development consultant at HumanR, Inc. He received his Master's degree in industrial-organizational psychology from George Mason University.

Marty Felsenthal

Partner, HLM ventures

Marty Felsenthal has spent his career working with emerging growth health care services and health care information technology companies, initially as an investment banker at Alex. Brown & Sons, where he worked closely with Ed Cahill and Russ Ray, and, since 1997, as a venture investor focused on health care services and health care information technology companies.

Marty led financings and serves on the boards of Teladoc, Change Healthcare, OnShift, and Vericare. Previously, Marty served on the boards of Aperio (acquired by Danaher), Titan Health (acquired by United Surgical Partners), U.S. Renal Care (acquired by Leonard Green), and PayerPath (acquired by Misys/Allscripts). As an investor, Marty has recruited more than 50 executives to the portfolio companies with whom he has partnered and has initiated many significant customer relationships. Marty received a BA from Princeton University and an MBA from the Stanford University Graduate School of Business.

Read full bio →

Cora M. Tellez

President & CEO, Sterling HSA

Cora serves as company President & CEO of Sterling HSA, a company she founded in 2004. Cora has 25 years of management experience in health care finance and delivery. Prior to founding Sterling HSA, Cora was President of the Health Plans division of Health Net, Inc., an insurance provider that operated in seven states and achieved revenue of $8 billion from health plans. She has also served as President of Prudential's western health care operations, CEO of Blue Shield of California, Bay Region and Regional Manager for Kaiser Permanente of Hawaii.

Cora received her master’s degree in public administration from California State University and is a Phi Beta Kappa graduate of Mills College where she received a BA degree and served as college Trustee.. She serves on the boards of HMS Holdings, Inc., (NASDAQ:HMSY) and Practice Fusion, a venture-backed company. She also serves on several nonprofit organizations such as the Institute for Medical Quality. She was a former board director of Crescent Healthcare, Bank of Hawaii, Glendale Federal Bank, Cal Fed Bank, Catellus Development Company and First Consulting Group. She has served on numerous non-profit boards, including The Cowell Foundation, Mills College, Holy Names University, and Philippine International Aid. She helped found Asian Community Mental Health and Filipinos for Social Justice.

Cora has been recognized for her professional and community endeavors by such organizations as Women Healthcare Executives, the Asian Pacific Fund, and the Anti Defamation League. In April, 2013, she was awarded the Living Example Award by the Bay Area Tumor Institute, and in August, 2013, she was awarded the Del Beasley Award for Community Leadership in Oakland by the Progressive Oakland Women for Empowerment and Reform.

Read full bio →

Michael Bates

Medical Technology Investor and Advisor, Band of Angels

Mike Bates is Co-Head of the Life Science Screening Committee at the Band of Angels and an active member of the Life Science Angels. He has invested in over 30 startups, about two-thirds of which are medical technology related. His portfolio includes companies such as Practice Fusion, HealthCrowd, CogENT Therapeutics, and Aerin Medical.

He formerly served as a Director of Catheter Connections, Inc. and as a Director and Audit Committee Chairman of BÂRRX Medical, Emphasys Medical, and Satiety.

Prior to becoming an angel investor, Mr. Bates served as Chief Financial Officer of four successful life science companies, all of which were sold at premium valuations generating high rates of return for their investors, including St. Francis Medical Technologies, Inc. (sold to Kyphon in January 2007), Silicon Genetics (sold to Agilent Technologies in 2004), Collagen Aesthetics, Inc. (sold to Inamed in 1999) and Penederm Incorporated (sold to Mylan Laboratories in 1998).

Mr. Bates is a certified public accountant (non-practicing), having begun his career at Deloitte LLP and has also held positions at Tandem Computers Inc. He is a graduate of California State University, East Bay and received an MBA in Finance from the University of California at Berkeley.

Read full bio →

Michael T. Esquivel

Partner, Fenwick & West

Michael Esquivel focuses his practice on strategic counseling to emerging and high-growth companies primarily in the digital/mobile health, Internet, social networking, information technology and clean technologies industries in all aspects of general corporate and corporate securities law—from formation and corporate governance responsibilities to equity incentives and employment issues to intellectual property and commercial transactions. He has negotiated and structured a wide variety of corporate transactions including: seed and venture capital financings, initial public offerings, mergers and acquisitions, corporate reorganizations and debt financings. In addition, Michael has represented and advised venture capitalists and investment banks.

Michael's activity in the growing digital health and healthcare IT industries includes serving as an advisor to the sector's leading incubator, Rock Health. He is a regular contributor to Fenwick's Life Sciences Legal Insights blog where he writes about digital health and mhealth topics.

Among the clients Michael has represented are:
Amyris, Inc., Andreessen Horowitz, Atlantic Bridge, Dropbox, Inc., Everlane, Inc., Facebook, Inc., goBalto, Inc., GoPro, Groupon, Inc., HealthTap, Mango Health, Mimosa Networks, Inc., MongoDB, Inc., Orca Health, Inc., Path, Inc., Pinterest, Quantcast Corporation, Quixey, Inc., Rock Health, Sequoia Capital, Tile, Ustream, Inc., West Summit Capital, WeWork

Read full bio →

Nina Kjellson

General Partner, InterWest Partners

Nina Kjellson has been investing in health care at InterWest since 2002 and has been a Managing Director at the firm since 2008. Current investments include Alvine Pharmaceuticals, Alt12, Cebix, Eiger Biopharmaceuticals, Labrys Biologics, Lycera, Ocera (OCRX), PrimeraDx, and WellTok. Nina also co-sponsored InterWest's investment in TESARO (TSRO). Previous investments include Aspreva (ASPV; acquired by Galenica), NovaCardia (acquired by Merck,) CNS Therapeutics (acquired by Covidien) and Trius Therapeutics (TSRX; acquired by Cubist).

Nina also leads InterWest's cross-sector initiative in health care IT and is co-chair of the Consumer Medicine Summit, a forum for entrepreneurs at the intersection of health care and consumer innovation. She serves as a mentor to Nike+ and BlueprintHealth accelerators. Prior to joining InterWest, Nina was at Bay City Capital, Oracle Partners and the Kaiser Family Foundation. She is a graduate of Stanford University with a degree in Human Biology.

Read full bio →

Laureen DeBuono

Partner, FLG Partners

Laureen joined FLG in 2011 and presently serves on the Firm’s Management Committee. Laureen has over 30 years of senior management experience as President and CEO, COO, CFO and General Counsel of various private and public life sciences, medical technology, consumer products and technology companies. Additionally, she has served as a member of the Board of Directors of both public and private companies, and has chaired their respective Audit Committees.

Laureen helps companies succeed by assisting them with corporate and financial strategy, including early stage financing and commercial growth strategies, successive fundraising and IPOs, public company advising and Wall Street communications, operational infrastructure guidance, M&A, restructurings, change management, and coaching at every level of the C-Suite. In particular, she excels at helping companies and CEOs navigate the many transitions that a company moves through, from early stage, to product development, scale-up, commercialization, M&A, integrations, restructurings and exits. During her career, Laureen has successfully raised over $350M in private and public financings, completed $5B in M&A transactions, retired over $500M in company debt, negotiated over $1B in revolver credit arrangements for companies, and has overseen three SOX-404 implementations. As EVP and General Counsel, she led the negotiations to sell Nellcor Puritan Bennett to Mallinkcrodt, Inc. (now Covidien) in a $2B+ transaction in 1997 as well as all post-merger integration. As EVP, CFO and COO, she led the negotiations to sell ReSound Corporation to GN Great Nordic in a $400M+ transaction in 1999, and assisted as a Board member in the sale of Invivo, Inc. to IMCG Group in a $400M transaction in 2004, and the sale of VISX, Inc. to AMO (now Abbott Ophthalmology) in a $2B transaction in 2005. Laureen also took Thermage, Inc., a global medical technology company, public in 2006 as its Chief Financial Officer, raising over $65M in both the private and public markets during her tenure. She was President and CEO of Coapt Systems, Inc., a global surgical products company from 2008-2010, and secured bridge financing to expand its product lines prior to the acquisition of certain of its businesses to MicroAire Surgical in later 2010. Prior to joining FLG, Laureen has served as a strategy, financial and management consultant to several public and private companies, assisting them with financings, market due diligence, operations, re-structurings, Wall Street communications, and exits. She is a frequent lecturer in corporate and financial strategy, fundraising in the private and public markets, M&A, board governance, restructurings, and post-merger integration. Laureen earned her B.A. from Duke University, Summa Cum Laude and Phi Beta Kappa, an M.A. from Stanford University as a Stanford Fellow, and a J.D. from New York University School of Law where she was a Root-Tilden Scholar. She is a member of the State Bar of California, as well as alumnus of the Directors’ College at Stanford University School of Law (2009, 2007, and 2005). Laureen is on the Board of Directors of Turtle Beach Holdings (NASDAQ: HEAR), a gaming headset and sound technology company where she is Chair of Governance and Nominating Committee; and and Cradle Holdings, LLC, a private luxury goods retail company. Until its acquisition by Mallinkcrodt, Inc. in March, 2014, she was on the board of Cadence Pharmaceuticals (NASDAQ: CADX), a specialty pharma company. Laureen has attended the Stanford Directors’ College in 2014, 2009, 2007, and 2005.

Read full bio →

Mark Cameron

Senior Vice President, Specialty Finance Division of Square 1 Bank

Over the last 25 years, Mark has provided creative financing solutions to hundreds of companies across the country. As Senior Vice President of the Specialty Finance division at Square 1 Bank, Mark provides creative, non-dilutive and streamlined accounts receivable - based credit solutions for technology and life science companies. He focuses on entrepreneur-backed, angel or venture-backed companies with a need for capital without additional dilution. Prior to Square 1 Bank, Mark was co-founder and President of Sand Hill Finance, a private finance company focused on emerging growth technology companies, which was acquired by Square 1 Bank in 2013. Mark has held senior positions at Imperial Bank of California, Sand Hill Capital and Silicon Valley Bank.

Aftab Jamil, CPA, FCA

Assurance Partner, BDO

Aftab has over 17 years of experience in public accounting. He has substantial experience in serving medical device, life sciences and technology sectors. Aftab has served public and private companies ranging from start-up, development stage enterprises to established multinational companies.

Aftab has significant experience with SEC reporting, mergers and acquisitions, international operations and strategic partnerships. He has participated in the preparation of numerous IPOs and secondary public equity and debt registration statement filings as well as on-going Securities and Exchange Commission reporting.

Aftab has also spent substantial time assisting publicly held clients and their audit committees in understanding, evaluating, and implementing the Sarbanes-Oxley Act (including preparations for reporting on internal controls under Section 404). In addition, Aftab has been a key contributor in multiple publications and “Thought Leadership” projects on related topics. He has also written articles on emerging accounting and financial reporting issues. Prior to joining BDO, Aftab was a partner in the Technology and Biotech Practice of a Big Four accounting firm.

American Institute of Certified Public Accountants
Institute of Chartered Accountants in England and Wales

International Diploma in Accounting Studies, Oxford Brooks University
Bachelor of Commerce Degree, Punjab University

Read full bio →

Michael O'Donnell

Partner, Morrison & Foerster LLP

Michael O'Donnell is a partner in the Palo Alto office of Morrison & Foerster LLP, specializing in corporate and securities law. He has more than 30 years of experience providing general corporate representation to biopharmaceutical and other life sciences companies. He offers particular expertise in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions. He represents numerous public and private biopharmaceutical, medical device, diagnostic, and instrumentation companies.

Thomas E. Duley

Partner, King & Spalding

Tom Duley, a partner in King & Spalding’s Silicon Valley Corporate Practice Group, concentrates his practice on technology transactions for life sciences clients. Mr. Duley negotiates, drafts and manages intellectual property and commercial transactions for life sciences companies, including collaboration agreements between biotechnology and pharmaceutical companies, licensing agreements with commercial businesses and academic institutions, supply and manufacturing agreements, distribution agreements and asset purchases and sales involving drug products and manufacturing facilities.

In the areas of therapeutics, diagnostics and medical devices, Mr. Duley has worked with clients throughout the corporate lifecycle, from startup entities obtaining their first university in-license to large public corporations restructuring their product holdings. Mr. Duley is also an Adjunct Professor at UC Hastings College of the Law, where he teaches a course in international business negotiations.

Read full bio →

Dean Hovey

CEO, DigiFit

Dean Hovey, a native of Silicon Valley, joined Digifit, Inc. as its president and CEO in the fall of 2011. Digifit combines mobile personal technology with experience design to help people form lifelong healthy habits.

Over the past 30 years Dean helped start 12 technology based companies. He has held senior executive team positions in two public companies. His personal experience spans retail, product design, entrepreneurship, business development, general management and venture capital.

During the early nineties Dean served as general partner of Avalon Ventures, a premier seed venture capital fund sponsored by the venture firms Kleiner Perkins, IVP, Sequoia Capital, and Norwest Ventures. Avalon formed attractive deals with unprecedented success rates.

While attending Stanford University Mr. Hovey created a new medical instrument to improve differential white blood cell counts. He founded Hovey/Kelley Design to take the instrument from prototype to production design. Within a year Hovey/Kelley added a number of clients including Apple Computer. The firm merged with Matrix and ID Two in 1991 to form IDEO.

Dean is the author of several patents including the patent for Apple Computer’s mouse. He earned BS and MS degrees from Stanford University in General Engineering Product Design.

Read full bio →

Early Registration
Sign up and get
tickets for only $895